Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EBIRE: Phase 1 Study of High Fluence LED-Red Light in Fitzpatrick Skin Types I to III

NCT03433222 is registered in ClinicalTrials.gov with VA Northern California Health Care System as lead sponsor.

NCT NCT03433222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03433222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EBIRE: Phase 1 Study of High Fluence LED-Red Light in Fitzpatrick Skin Types I to III
Lead sponsor
VA Northern California Health Care System
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2018
Completion date
January 8, 2019
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibrosis, hypertrophic skin, keloid, scar, skin diseases